Genetic results of uncertain clinical significance are being returned to parents following newborn screening, representing a paradigm change in how society considers health and illness. 'Cystic Fibrosis screen positive, inconclusive diagnosis' (CFSPID) is a designation given to newborns with a positive screening result for, but not a definitive diagnosis of, cystic fibrosis. We explored the psychological impact of receiving a CFSPID result on parents. Five semi-structured interviews were conducted with eight parents whose children have CFSPID. Interpretative phenomenological analysis identified these themes: "The way we were told": 'diagnosis as a traumatic event' focused on how parents were distressed and dissatisfied by the initial screen...
As whole genome sequencing is being considered as a tool to deliver expanded newborn screening (NBS)...
OBJECTIVE: To investigate the psychosocial implications for families whose infant was identified as ...
As whole genome sequencing is being considered as a tool to deliver expanded newborn screening (NBS)...
Newborn screening for cystic fibrosis has resulted in diagnosis often before symptoms are recognised...
Newborn screening for cystic fibrosis has resulted in diagnosis often before symptoms are recognised...
OBJECTIVE: To explore the psychosocial implications of diagnostic uncertainty that result from incon...
Objective To explore the psychosocial implications of diagnostic uncertainty that result from inconc...
Objective To explore the psychosocial implications of diagnostic uncertainty that result from inconc...
Background: An inconclusive diagnosis of cystic fibrosis (CF) after positive newborn screening (NBS)...
This study was designed to develop a framework for understanding parents ’ perspectives about the ps...
This study was designed to develop a framework for understanding parents ’ perspectives about the ps...
The clinical advantages of the newborn screening programme (NBS) in the UK are well described in the...
The clinical advantages of the newborn screening programme (NBS) in the UK are well described in the...
BACKGROUND: The risk of psychosocial harm in families of infants with false-positive (FP) newborn bl...
BACKGROUND: The risk of psychosocial harm in families of infants with false-positive (FP) newborn bl...
As whole genome sequencing is being considered as a tool to deliver expanded newborn screening (NBS)...
OBJECTIVE: To investigate the psychosocial implications for families whose infant was identified as ...
As whole genome sequencing is being considered as a tool to deliver expanded newborn screening (NBS)...
Newborn screening for cystic fibrosis has resulted in diagnosis often before symptoms are recognised...
Newborn screening for cystic fibrosis has resulted in diagnosis often before symptoms are recognised...
OBJECTIVE: To explore the psychosocial implications of diagnostic uncertainty that result from incon...
Objective To explore the psychosocial implications of diagnostic uncertainty that result from inconc...
Objective To explore the psychosocial implications of diagnostic uncertainty that result from inconc...
Background: An inconclusive diagnosis of cystic fibrosis (CF) after positive newborn screening (NBS)...
This study was designed to develop a framework for understanding parents ’ perspectives about the ps...
This study was designed to develop a framework for understanding parents ’ perspectives about the ps...
The clinical advantages of the newborn screening programme (NBS) in the UK are well described in the...
The clinical advantages of the newborn screening programme (NBS) in the UK are well described in the...
BACKGROUND: The risk of psychosocial harm in families of infants with false-positive (FP) newborn bl...
BACKGROUND: The risk of psychosocial harm in families of infants with false-positive (FP) newborn bl...
As whole genome sequencing is being considered as a tool to deliver expanded newborn screening (NBS)...
OBJECTIVE: To investigate the psychosocial implications for families whose infant was identified as ...
As whole genome sequencing is being considered as a tool to deliver expanded newborn screening (NBS)...